GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,517.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 1,766.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,098.12m
  • Volume: 9,107,686
  • Market Cap: £62,168m
  • RiskGrade: 129

Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian
GlaxoSmithKline's mulled HIV spin-off 'bigger th... 23-Oct-2014 Telegraph
GlaxoSmithKline shares rise after drugs giant pl... 23-Oct-2014 Daily Mail
Glaxo to float its HIV cures as a standalone £15... 23-Oct-2014 The Independent
RBS chairman to head embattled GlaxoSmithKline 26-Sep-2014 Guardian
Royal Bank of Scotland chairman to move to Glaxo... 25-Sep-2014 Guardian
GSK to start production of Ebola vaccine as test... 29-Aug-2014 Guardian
MARKET REPORT: Evotec deal just the tonic for Gl... 28-Aug-2014 Express & Star
GlaxoSmithKline faces fresh drug bribery claims ... 13-Aug-2014 Guardian
Now GlaxoSmithKline faces claims of bribery from... 13-Aug-2014 Daily Mail
GlaxoSmithKline faces fresh bribery allegations ... 13-Aug-2014 The Independent
Peter Humphrey trial: GlaxoSmithKline to blame, ... 08-Aug-2014 Telegraph
GlaxoSmithKline looking to bag RBS chairman Sir ... 08-Aug-2014 Telegraph
Sir Philip Hampton may quit RBS in potential mov... 08-Aug-2014 Guardian
GlaxoSmithKline affirms policy of anti-corruptio... 24-Jul-2014 Guardian
Pained Glaxo sees sales take turn for the worse 24-Jul-2014 Express & Star

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,517.00p
Change Today 10.00p
% Change 0.66 %
52 Week High 1,766.50
52 Week Low 1,264.00
Volume 9,107,686
Shares Issued 4,098.12m
Market Cap £62,168m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.81% below the market average57.81% below the market average57.81% below the market average57.81% below the market average57.81% below the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average
Price Trend
32.70% above the market average32.70% above the market average32.70% above the market average32.70% above the market average32.70% above the market average
60.87% above the sector average60.87% above the sector average60.87% above the sector average60.87% above the sector average60.87% above the sector average
Income
69.40% above the market average69.40% above the market average69.40% above the market average69.40% above the market average69.40% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.68% below the market average36.68% below the market average36.68% below the market average36.68% below the market average36.68% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 02-Jun-2025

Time Volume / Share Price
15:49 7 @ 1,516.50p
15:20 0 @ 1,514.50p
15:19 0 @ 1,514.50p
14:59 24 @ 1,510.50p
17:12 10,405 @ 1,517.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page